Trial Details

WITHDRAWN
Basic Information
Clinical ID c247
Identifier NCT02771457
Trial Title Managing Infliximab Reinduction After Temporary Discontinuation of Drug
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Disease
Interventions DRUG: Infliximab at weeks 0,2, and 6|DRUG: Infliximab at weeks 0,4, and 8|DRUG: Infliximab at weeks 0 and 8
Participant Information
Sponsor NYU Langone Health
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2025-07-16
Primary Completion Date 2025-07-19
Completion Date 2025-07-19